banner
Targeted methylprednisolone nanoliposomes
Inquiry

Cat. No.: X26-05-ZQ913

Targeted methylprednisolone nanoliposomes

Synonym: Targeted methylprednisolone NLs; Methylprednisolone targeted nanoliposomes; Methylprednisolone targeted NLs

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This formulation provides targeted methylprednisolone nanoliposomes (T-MP NLs) engineered for highly selective surface interactions. The nanostructures are composed of a fluid-phase phospholipid bilayer into which specific affinity ligands are chemically integrated. Methylprednisolone is distributed between the lipid bilayer and the internal aqueous core based on its partition coefficient. The small particle diameter is carefully maintained to optimize structural uniformity.
Source
Custom synthesis
Functional Group
Methylprednisolone
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.